Regression of high-grade squamous intraepithelial cervical lesions and associated risk factors (RECER).
Lukas Dostalek, Daniel Brynda, Radim Marek...
https://pubmed.ncbi.nlm.nih.gov/40215795/Actively Recruiting
Led by General University Hospital, Prague · Updated on 2026-02-25
300
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to understand how often severe cervical precancerous lesions CIN 2 and CIN 3 naturally get better without surgery. It also compares patients treated with close monitoring and those who had surgical removal conization by looking at HPV test results and cell changes. The study will identify factors that predict lesion improvement and develop a model to estimate the chances of regression. The study follows women aged 18 to 40 who have confirmed CIN 2 or CIN 3 lesions visible during colposcopy. Participants undergo colposcopic exams every four months to monitor lesion changes. If the lesion worsens, surgery is recommended if persistent, patients can choose continued observation or surgery if the lesion improves, a biopsy is taken to confirm healing. HPV status and cell changes are also monitored, along with other factors like age and HPV type. Participants will have regular colposcopic evaluations and tests over three years to track lesion regression and changes in HPV and cytology results. The main outcome is the rate of lesion regression based on tissue samples. Researchers will also assess HPV clearance and cell normalization rates, considering factors that might influence outcomes. Safety and disease progression are monitored throughout, with data used to build a predictive model for lesion regression.
CONDITIONS
Regression of Cervical Precancerous Lesions and Associated Risk Factors
L
Lukas Dostalek
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
General University Hospital, Prague
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants undergo colposcopic evaluations at regular intervals to assess the severity and progression of cervical precancerous lesions without surgical intervention.
Colposcopic evaluations every 4 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Lukas Dostalek, Daniel Brynda, Radim Marek...
https://pubmed.ncbi.nlm.nih.gov/40215795/General University Hospital, Prague
Lead Sponsor